Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Black Diamond Therapeutics, Inc. - Common Stock (NQ:BDTX)

2.280 -1.270 (-35.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Black Diamond Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today! 
Via InvestorPlace
News headline image
Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Black Diamond Therapeutic ↗
 
Via Benzinga
News headline image
Black Diamond Therapeutics Stock is Shooting Higher Today: Here's Why ↗
Black Diamond Therapeutics Inc (NASDAQ: BDTX) announced initial  
Via Benzinga
News headline image
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
Via Benzinga
News headline image
Tesla And Nvidia Lead The Charge As Stocks Surge: Top Trends Of The Day ↗
 
Via Benzinga
News headline image
Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42.... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
Via Benzinga
News headline image
Black Diamond Therapeutics’ (NASDAQ: BDTX) BDTX-1535 Proves Promising for EGFR Mutated NSCLC and GBM
Black Diamond Therapeutics has announced encouraging initial data from a Phase 1 study of BDTX-1535, an investigational fourth-generation EGFR MasterKey 
Via Spotlight Growth
News headline image
Dow Surges Over 100 Points; Walgreens Lowers Earnings Forecast ↗
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.39% to 33,845.82 while the NASDAQ rose 0.55% to 13,408.91. The S&P 500,... 
Via Benzinga
Black Diamond Therapeutics Inc. (NASDAQ: BDTX) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
News headline image
American Rebel (AREB) Stock Jumps on 1-for-25 Reverse Split ↗
American Rebel (AREB) stock is a hot topic among traders on Tuesday after the self-defense company underwent a reverse stock split. 
Via InvestorPlace
News headline image
Why Is Black Diamond Therapeutics (BDTX) Stock Up 82%? ↗
Black Diamond Therapeutics (BDTX) stock is seeing massive gains on Tuesday after releasing data from a Phase 1 clinical study. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Recap: Black Diamond Therapeutic Q1 Earnings ↗
Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Black Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Days
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Black Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535 and Preclinical Data on BDTX-1535 and BDTX-4933 at the 2023 American Association of Cancer Research Annual Meeting
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.